Calidi Biotherapeutics, Inc. Investing Cash Flow
Calidi Biotherapeutics, Inc. (CLDI) reported Investing Cash Flow of -$38.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-13
- Calidi Biotherapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$33.00K.
- Calidi Biotherapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$5.00K.
- Calidi Biotherapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$79.00K.
- Calidi Biotherapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$27.00K.
- Calidi Biotherapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$170.00K.
- Calidi Biotherapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$16.00K.
- Calidi Biotherapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$478.00K.
- Calidi Biotherapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$494.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 3 month as first filed | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$33.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$38.00K 10-Q · filed 2026-08-13 | -$117.00K derived: sum of 3 quarters · filed 2026-08-13 | -$144.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | -$5.00K 10-Q · filed 2026-05-14 | -$84.00K derived: sum of 2 quarters · filed 2026-05-14 | -$111.00K derived: sum of 3 quarters · filed 2026-05-14 | -$168.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | -$79.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$106.00K derived: sum of 2 quarters · filed 2026-03-27 | -$163.00K derived: sum of 3 quarters · filed 2026-08-13 | -$170.00K 10-K · filed 2026-03-27 | ||||
| 2025-09-30 | -$27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$84.00K derived: sum of 2 quarters · filed 2026-08-13 | -$91.00K 10-Q · filed 2025-11-13 | -$96.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | -$57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$64.00K 10-Q · filed 2026-08-13 | -$69.00K derived: sum of 3 quarters · filed 2026-08-13 | -$75.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | -$7.00K 10-Q · filed 2026-05-14 | -$12.00K derived: sum of 2 quarters · filed 2026-05-14 | -$18.00K derived: sum of 3 quarters · filed 2026-05-14 | -$18.00K derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$11.00K derived: sum of 2 quarters · filed 2026-03-27 | -$11.00K derived: sum of 3 quarters · filed 2026-03-27 | -$16.00K 10-K · filed 2026-03-27 | ||||
| 2024-09-30 | -$6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$6.00K derived: sum of 2 quarters · filed 2025-11-13 | -$11.00K 10-Q · filed 2025-11-13 | -$46.00K derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$5.00K 10-Q · filed 2025-08-08 | -$40.00K derived: sum of 3 quarters · filed 2025-08-08 | -$103.00K derived: sum of 4 quarters · filed 2025-08-08 | ||||
| 2024-03-31 | -$5.00K 10-Q · filed 2025-05-14 | -$40.00K derived: sum of 2 quarters · filed 2025-05-14 | -$103.00K derived: sum of 3 quarters · filed 2025-05-14 | -$346.00K derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | -$35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$98.00K derived: sum of 2 quarters · filed 2025-03-31 | -$341.00K derived: sum of 3 quarters · filed 2025-03-31 | -$478.00K 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | -$63.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$306.00K derived: sum of 2 quarters · filed 2024-11-12 | -$443.00K 10-Q · filed 2024-11-12 | -$604.00K derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | -$243.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$380.00K 10-Q · filed 2024-08-13 | -$720.31K 10-Q · filed 2023-08-21 | -$541.00K derived: sum of 3 quarters · filed 2024-08-13 | -$874.00K derived: sum of 4 quarters · filed 2024-08-13 | |||
| 2023-03-31 | -$137.00K 10-Q · filed 2024-05-14 | -$425.85K 10-Q · filed 2023-05-15 | -$298.00K derived: sum of 2 quarters · filed 2024-05-14 | -$631.00K derived: sum of 3 quarters · filed 2024-05-14 | -$631.00K derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | -$161.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$494.00K derived: sum of 2 quarters · filed 2024-03-15 | -$494.00K derived: sum of 3 quarters · filed 2024-03-15 | -$494.00K 10-K · filed 2024-03-15 | $187.69M 10-K · filed 2023-03-31 | |||
| 2022-09-30 | -$333.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$333.00K derived: sum of 2 quarters · filed 2023-11-14 | -$333.00K 10-Q · filed 2023-11-14 | $189.59M 10-Q · filed 2022-11-14 | -$333.00K derived: sum of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-21 | $0.00 10-Q · filed 2023-08-21 | $0.00 derived: sum of 3 quarters · filed 2023-08-21 | |||||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-15 | $0.00 derived: sum of 2 quarters · filed 2023-05-15 | ||||||
| 2021-12-31 | $0.00 derived: 10-K 9 month − 10-Q 6 month · filed 2023-03-31 | -$230.00M 10-K · filed 2023-03-31 | ||||||
| 2021-09-30 | -$230.00M 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |